Ron Bates

VP, CMC Process Development and Technical Operations

Dr. Ronald Bates is the Vice President of CMC Process Development and Manufacturing at Immunovant (IMVT). At IMVT, Ron leads the development and manufacturing of novel biological moieties targeting immunotherapies. Prior to IMVT, he led the Manufacturing Science and Technology (MST) group at Bristol-Myers Squibb (BMS) in Syracuse, NY and was responsible for monitoring, validating, transferring, and improving late-stage and commercial manufacturing processes. Before BMS, Ron led the process development and MST group at Allergan (now part of AbbVie) focusing on developing and manufacturing wild-type and recombinant prokaryotic-based systems as well as developing novel technologies including automated, high throughput methods and disposable manufacturing processes. Ron started his career at Pfizer purifying small molecule moieties using chiral, normal phase, and reversed phase chromatography in traditional, flash, and multi-column continuous systems. He received his Ph.D. from the University of Maryland, Baltimore County in Biochemical Engineering under Doug Frey studying mathematical modeling of ion exchange chromatography and his B.S. in Chemical Engineering from Rensselaer Polytechnic Institute. Ron is also active in the biopharma industry sitting on conference planning, conference scientific, and journal editorial boards in addition to chairing and presenting at international conferences and authoring research articles and patents.

Talks About
#manufacturing #sciencetechnology

Preferred Locations
#NorthAmerica